mianserin has been researched along with Menopause in 4 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine is an effective treatment for major depression in perimenopausal and postmenopausal women whose depression precedes ERT use and does not respond to ERT or whose depression develops after ERT is initiated." | 6.70 | An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy. ( Cohen, LS; Groninger, H; Joffe, H; Nonacs, R; Soares, C; Soares, CN, 2001) |
| "Psychotropic drug lerivon (mianserin hydrochloride) was tested in patients with psychovegetative disorders as a result of surgical menopause (postovariectomy syndrome)." | 3.69 | [The pharmacotherapy of psychoautonomic disorders in patients with the surgical menopause syndrome]. ( Gudkova, MA; Solov'eva, AD, 1997) |
| "Mirtazapine is an effective treatment for major depression in perimenopausal and postmenopausal women whose depression precedes ERT use and does not respond to ERT or whose depression develops after ERT is initiated." | 2.70 | An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy. ( Cohen, LS; Groninger, H; Joffe, H; Nonacs, R; Soares, C; Soares, CN, 2001) |
| "Mirtazapine is an antidepressant with mode of action different from other currently available antidepressants." | 2.40 | Mirtazapine: other indications. ( Falkai, P, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albertazzi, P | 1 |
| Gudkova, MA | 1 |
| Solov'eva, AD | 1 |
| Falkai, P | 1 |
| Joffe, H | 1 |
| Groninger, H | 1 |
| Soares, CN | 1 |
| Nonacs, R | 1 |
| Cohen, LS | 1 |
| Soares, C | 1 |
2 reviews available for mianserin and Menopause
| Article | Year |
|---|---|
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapin | 2006 |
Mirtazapine: other indications.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Clinical Trials as Topic; Depressive Dis | 1999 |
1 trial available for mianserin and Menopause
| Article | Year |
|---|---|
An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy.
Topics: Adult; Antidepressive Agents; Depression; Estradiol; Female; Hormone Replacement Therapy; Humans; Me | 2001 |
1 other study available for mianserin and Menopause
| Article | Year |
|---|---|
[The pharmacotherapy of psychoautonomic disorders in patients with the surgical menopause syndrome].
Topics: Adult; Affective Symptoms; Antidepressive Agents, Second-Generation; Autonomic Nervous System Diseas | 1997 |